To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Sponsors:
Rep. Harshbarger, Diana [R-TN-1]
Status: Referred to the House Committee on Energy and Commerce.
(2025-01-23)
View Original Bill Text
Summary Coming Soon
This bill hasn't been summarized yet. New summaries are generated nightly.